Tag: Entheon Biomedical - Psychedelic Alpha

Our 2022 Year in Review is now live.

Read more about the article Entheon Biomedical Announces Non-Brokered Private Placement Financing

Entheon Biomedical Announces Non-Brokered Private Placement Financing

Post published:April 5, 2022
Post category:Press Release

Read more about the article Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel & New Clinical Research Platform

Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel & New Clinical Research Platform

Post published:March 29, 2022
Post category:Press Release

Read more about the article Entheon Biomedical Announces Enrollment in Phase 1 Study of DMT

Entheon Biomedical Announces Enrollment in Phase 1 Study of DMT

Post published:March 15, 2022
Post category:Press Release

Read more about the article Entheon Biomedical Announces EBIQ-101 First-Patient Dose

Entheon Biomedical Announces EBIQ-101 First-Patient Dose

Post published:February 24, 2022
Post category:Press Release

Read more about the article Entheon Biomedical Partners with Wavepaths on Upcoming Observational Study

Entheon Biomedical Partners with Wavepaths on Upcoming Observational Study

Post published:February 16, 2022
Post category:Press Release

Read more about the article Entheon Biomedical Announces the Approval of DMT Clinical Trial

Entheon Biomedical Announces the Approval of DMT Clinical Trial

Post published:February 3, 2022
Post category:Press Release

Read more about the article Entheon Biomedical Subsidiary, HaluGen Life Sciences, Announces Agreement with Psychedelics Today

Entheon Biomedical Subsidiary, HaluGen Life Sciences, Announces Agreement with Psychedelics Today

Post published:January 18, 2022
Post category:Press Release

Read more about the article Entheon Biomedical Corp. Files Preliminary Shelf Prospectus

Entheon Biomedical Corp. Files Preliminary Shelf Prospectus

Post published:January 18, 2022
Post category:Press Release

Read more about the article Entheon Biomedical Provides Update on DMT Human Trial and Announces Regulatory Submission to Ethics Committee

Entheon Biomedical Provides Update on DMT Human Trial and Announces Regulatory Submission to Ethics Committee

Post published:January 6, 2022
Post category:Press Release

Read more about the article Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel

Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel

Post published:December 21, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.